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Abstract
Background: Cancer cells present a sustained de novo fatty acid synthesis with an increase of saturated and
monounsaturated fatty acid (MUFA) production. This change in fatty acid metabolism is associated with overexpression of
stearoyl-CoA desaturase 1 (Scd1), which catalyses the transformation of saturated fatty acids into monounsaturated fatty
acids (e.g., oleic acid). Several reports demonstrated that inhibition of Scd1 led to the blocking of proliferation and induction
of apoptosis in cancer cells. Nevertheless, mechanisms of cell death activation remain to be better understood.
Principal Findings: In this study, we demonstrated that Scd1 extinction by siRNA triggered abolition of de novo MUFA
synthesis in cancer and non-cancer cells. Scd1 inhibition-activated cell death was only observed in cancer cells with
induction of caspase 3 activity and PARP-cleavage. Exogenous supplementation with oleic acid did not reverse the Scd1
ablation-mediated cell death. In addition, Scd1 depletion induced unfolded protein response (UPR) hallmarks such as Xbp1
mRNA splicing, phosphorylation of eIF2a and increase of CHOP expression. However, the chaperone GRP78 expression,
another UPR hallmark, was not affected by Scd1 knockdown in these cancer cells indicating a peculiar UPR activation.
Finally, we showed that CHOP induction participated to cell death activation by Scd1 extinction. Indeed, overexpression of
dominant negative CHOP construct and extinction of CHOP partially restored viability in Scd1-depleted cancer cells.
Conclusion: These results suggest that inhibition of de novo MUFA synthesis by Scd1 extinction could be a promising anti-
cancer target by inducing cell death through UPR and CHOP activation.
Citation: Minville-Walz M, Pierre A-S, Pichon L, Bellenger S, Fe `vre C, et al. (2010) Inhibition of Stearoyl-CoA Desaturase 1 Expression Induces CHOP-Dependent
Cell Death in Human Cancer Cells. PLoS ONE 5(12): e14363. doi:10.1371/journal.pone.0014363
Editor: Michael Polymenis, Texas A&M University, United States of America
Received July 23, 2010; Accepted November 26, 2010; Published December 16, 2010
Copyright:  2010 Minville-Walz et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from INSERM, Region Bourgogne and the Centre National Interprofessionnel de l’Economie Laitiare. The funders
had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: mickael.rialland@u-bourgogne.fr
. These authors contributed equally to this work.
Introduction
Cancer cells exhibit metabolism alterations characterised by
increased glycolysis and lipogenesis [1,2]. Active proliferating
cancer cells present not only quantitative changes in de novo lipid
biosynthesis but also modifications of lipid membrane composition
affecting membrane fluidity, signal transduction and gene
expression [3,4]. Changes in lipid membrane composition are
observed in a wide variety of cancers, mainly characterised by
saturated (SFA) and monounsaturated fatty acid (MUFA)
accumulation which appears less due to increased uptake of
SFA and MUFA than to exacerbated endogenous fatty acids
synthesis, irrespective of adequate lipid nutritional supply
[5,6,7,8,9,10,11]. These modifications of SFA and MUFA content
are associated with the modulation of the expression and activity
of lipogenic enzymes. Thus, overexpression of acetyl Co-A
carboxylase a and fatty acid synthase, involved in the first steps
of fatty acid biosynthesis, were described in various cancers
[12,13,14,15,16,17].
Increased MUFA content could be also due to an up-regulation of
stearoyl Co-A desaturase (Scd, delta-9 desaturase) expression, the rate-
limiting enzyme of MUFA synthesis. Indeed, Scd catalyzes the
introduction of a double bond between carbons 9 and 10 of several
saturated fatty acids such as palmitic (16:0) and stearic (18:0) acids to
yield palmitoleic (16:1) and oleic (18:1) acids, respectively. This
endoplasmic reticulum resident enzyme exists under two isoforms in
humans, Scd1 and Scd5 [18]. Scd1 is found in almost all tissues with a
major expression in liver while Scd5 expression is restricted to pancreas
and brain. Scd1 expression, correlated with MUFA content, is
increased in hepatocellular adenoma, colonic and oesophageal
carcinoma, as well as in genetically- and chemically-induced tumors
[19,20,21]. For prostate cancer, two studies present contradictory
results on Scd1 expression level [22,23]. Thus, Scd1 expression can be
related to carcinogenesis processes involving alteration of proliferation/
apoptosis balance. Indeed, Scd1 over-expressing cells present a growth
advantage while scd1 knock-down leads to slower rates of cell
proliferation and cell death in vivo and in vitro [24,25,26,27]. The
mechanism of cell death observed in Scd1-deficient lung cancer cells
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e14363Figure 1. Efficient suppression of Scd1 expression and activity by siRNA targeting Scd1. A) U2OS cells were transfected with siRNA
control (scr) or with siRNA against Scd1 (Scd1.A and Scd1.B) and collected 24 and 48 h post-transfection for Scd1 mRNA expression by real time RT-
PCR. Scd1 mRNA expression was normalized to b-actin expression. Values represent the mean 6 SEM relative to Scd1 mRNA expression in scr-treated
U2OS cells at 24 h. *, p,0.05 vs. siRNA scr-treated cells by Anova analysis followed by Tuckey test. B) U2OS and SW480 cells were treated with
oligofectamine (-), siRNA control (scr) or with siRNA against Scd1 (Scd1.A and Scd1.B). Cells were collected 24 h after transfection for Scd1 expression
analysis by Western-Blotting. C) U2OS and SW480 cells treated 72 h with siRNA were incubated for further 6 h with [
14C] stearic acid and total lipid
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inhibition of the Akt pathway and activation of the AMPK pathway
[24,28]. Indeed, in absence of Scd1, the SFA content increases which
alleviates Akt activation normally obtained by MUFA (e.g. oleic acid)
for sustaining cell proliferation and survival [29]. Furthermore,
different cancer cells lacking Scd1 activity reduce de novo lipogenesis
through activation of the AMPK pathway [22,24]. The alteration of
lipid production in Scd1-deficient cells mainly concerns a reduction of
phospholipid biosynthesis, which triggers cellular stress and expression
of the apoptosis-related protein C/EBP homologous protein (CHOP/
GADD153) [26,27,30,31]. CHOP belongs to a peculiar stress pathway
named endoplasmic reticulum (ER) stress that may induce apoptosis.
ER stress is triggered by different stress conditions such as
alterations in post-translational protein status and lipid synthesis,
hypoxia, disruption of calcium homeostasis and nutrient depriva-
tion, and leads to the activation of an adaptive program, known as
the Unfolded Protein Response (UPR), to re-establish equilibrium
[32]. Activation of the canonical UPR engages three distinct
concerted signalling branches mediated by ER membrane
anchored sensors: RNA-dependent protein kinase (PKR)-like ER
kinase (PERK), activating transcription factor 6 (ATF6) and
inositol requiring enzyme 1a (IRE1a) [33]. In stressed cells, the
chaperone protein GRP78 dissociates from UPR sensors PERK,
ATF6 and IRE1a leading to their activation to first alleviate ER
stress. PERK phosphorylates the eukaryotic translation initiation
factor (eIF)2a, thereby inhibiting global protein synthesis. Active
ATF6 translocates to the Golgi and is cleaved from the membrane
by site-1 and -2 proteases. Then cleaved ATF6 localises to the
nucleus and induces transcription of Xbp1 and ER chaperones
such as GRP78. IRE1a disposes of an endoribonuclease activity
that alternatively splices the Xbp1 mRNA (sXbp1), which is
translated into an active transcription factor. However, in a severe
or prolonged stress, the UPR can trigger pro-apoptotic signals
through activation of the transcription factor CHOP, which acts to
repress the bcl-2 gene expression, thus down-regulating anti-
apoptotic Bcl-2 protein and rendering cells sensitive to the pro-
apoptotic effects of BH3-only proteins [34,35,36].
While these data clearly support the involvement of Scd1 as a
central regulator of lipogenesis in cancer cells, the link between
Scd1 and the induction of ER stress and cell death in cancer cells
remains to be better understood. In this study, we were
consequently interested in seeking for UPR induction in cancer
cells lacking Scd1 expression and in investigating the role of this
stress pathway on the cancer cell viability during Scd1 extinction.
We demonstrated that Scd1 depletion in cancer cells activated
UPR markers and induced cancer cell death with no effect on non
cancer cell viability. Moreover, we evidenced that CHOP
participated to Scd1-mediated cell death.
Results
Efficient inhibition of Scd1 expression and suppression of
de novo MUFA synthesis
In this study we investigated the effect of Scd1 silencing using
siRNA in different human cancer cell lines (U2OS, SW480 and
HCT116). Cancer cells were transfected with 75 nM siRNA
targeting unrelated human mRNA (siRNA scr) and Scd1 mRNA
(siRNA Scd1.A and Scd1.B). Both siRNA directed against Scd1
compared to control siRNA (scr) drastically suppressed expression
of Scd1 mRNA and protein as soon as 24 h after transfection
(Figures 1A and 1B).
As Scd1 catalyzes the conversion of stearic acid into oleic acid, a
decrease in oleic acid production would evidence the abolition of
Scd1 activity by siRNA targeting this enzyme. In order to address
Scd activity after 72 h of Scd1 silencing, we further treated U2OS
and SW480 cells for 6 h with radiolabelled [
14C] stearic acid
leading to measure the production of [
14C] oleic acid in Scd1-
deficient cells compared to control scr-treated cells. The
incorporation of [
14C] stearic acid was similar in siRNA scr and
Scd1-treated cells (data not shown). Cancer cells transfected by the
non-targeting human mRNA siRNA (scr) presented a desaturation
rate of 31.49% for U2OS and 25.66% for SW480. In the two cell
lines, Scd1 extinction led to a drop-off in oleic acid biosynthesis
with a remaining desaturation rate of 5.135% and 5.28% in U2OS
treated by siRNA Scd1.A and Scd1.B, respectively, and 5.89%
and 7.55%, respectively, in SW480 (Figure 1C). Furthermore, we
exposed U2OS cells for 24 h to the Scd1 inhibitors CVT-11127
and MF-438 (10 mM). We obtained similar capability with Scd1
inhibitors than siRNA directed against Scd1 to inhibit the
production of oleic acid from stearic acid in U2OS cells
(Figure 1D).
Altogether, these results demonstrated a drastic inhibition of
Scd activity in siRNA Scd1-treated cells. Moreover, in these
cancer cell lines, Scd1 appears as the main enzyme involved in the
endogenous production of oleic acid.
Scd1 extinction promotes apoptosis-cell death
In order to assess effect of Scd1 knockdown on cell viability, we
first determined cell number at 24 h, 48 h and 72 h post-
transfection using CyQuantH reagent which quantifies the amount
of nucleic acids. As soon as 48 h post-transfection, cell number was
significantly less in Scd1-depleted U2OS cells compared to control
cells. While relative fluorescence (RF) increased for siRNA scr-
treated cells all along the 72 h post-transfection, RF did not
significantly change for siRNA Scd1-silenced cells during the time
course. We observed that RF was twice fold higher in siRNA scr
cells compared to siRNA Scd1-depleted U2OS 72 h post-
transfection indicating proliferation inhibition or cell death
induction in Scd1-ablated cells (Figure 2A). Then, we demon-
strated by trypan blue exclusion cell count 72 h after transfection
of siRNA that Scd1 knockdown led to a diminution of cell viability
both in U2OS and SW480 cells but much more drastically in
U2OS cells (Figure 2B). More than 30% of Scd1 siRNA-treated
U2OS and approximately 20% of Scd1 siRNA-treated SW480
were positive for PI representing an increase of three and two folds
compared to siRNA scr-treated U2OS and SW480 cells,
respectively (Figure 2C). Inhibition of Scd1 activity by both
compounds (CVT-11127 and MF-438) also led to increase cell
death at 48 h in a dose-response manner (Figure 2D). However,
we found that these compounds differently affected cell viability
with CVT 11127 more potent for cell death induction than MF-
438 in U2OS. Moreover, we showed that Scd1 depletion induced
extraction was performed. Scd activity was evaluated by HPLC as the rate of [
14C] stearic acid conversion into [
14C] oleic acid in cells treated with
siRNA for 72 h. Scd activity was expressed as the % ratio of [
14C] oleic acid to [
14C] oleic and stearic acids. Values represent the mean 6 SEM from at
least two separate experiments. *, p,0.05 vs. siRNA scr-treated cells by Anova analysis followed by Tuckey test. A representative expression of Scd1
protein was shown for 72 h of siRNA treatment. D) U2OS cells were exposed to DMSO as vehicle, Scd1 inhibitors (CVT-11127 or MF-438) at 10 mM for
24 h and prepared as above C) for measuring Scd activity. Values represent the mean 6 SEM from three experiments. *, p,0.05 vs. vehicle-treated
cells by Anova analysis followed by Tuckey test.
doi:10.1371/journal.pone.0014363.g001
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PLoS ONE | www.plosone.org 3 December 2010 | Volume 5 | Issue 12 | e14363Figure 2. Scd1 knockdown promoted apoptosis-cell death. A) U2OS cells were treated with siRNA scr (control) and targeting Scd1 (Scd1.A
and Scd1.B), and collected 24 h, 48 h or 72 h post-transfection. Proliferation status was determined by the CyQuantH proliferation assay. Each value is
the mean of relative fluorescence units 6 SEM of triplicate and representative of three independent experiments. B) U2OS and SW480 cells were
cultured for 72 h post-siRNA transfection and harvested for trypan blue dye exclusion assay. Values are the mean 6 SEM of triplicate and
representative of two others independent experiments. C) U2OS ad SW480 cells treated 72 h with siRNA were collected and total cell death was
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3 activity and PARP cleavage (Figures 2E and 2F).
We then postulated that cell death was triggered by reduction of
oleic acid cell content. Thus, we undertook to supplement siRNA
Scd1-depleted cells with 100 mM oleic acid in order to evaluate the
capability of exogenous supplementation to reverse cell death.
Figure 2G evidenced that exposure of Scd1-deficient U2OS cells
to exogenous oleic acid did not change the rate of cytotoxicity.
Inhibition of Scd1 expression activates partially unfolded
protein response
Perturbations of ER homeostasis lead to ER stress by UPR
activation that could trigger cell death. In order to monitor
activation of the UPR pathway, we investigated the expression
level of GRP78, phospho-eIF2a and unconventional splicing of
Xbp1 mRNA. U2OS and SW480 cells have the functional
machinery to respond to thapsigargin-induced ER stress, as we
observed splicing of Xbp1, up-regulation of GRP78 and phospho-
eIF2a expression (Figures 3A and B). Then, we analyzed these ER
stress markers in Scd1-deficient cells. Abolition of Scd1 in U2OS
and SW480 cells led to a partial processing of Xbp1 mRNA:
spliced- and hybrid-Xbp1 (s- and h-Xbp1) mRNA species were
increased in Scd1-deficient cells indicating activation of IRE1a
arm in both cell lines, in a more pronounced manner in SW480
cells (Figure 3A). Translation of s-Xbp1 produces the functional
Xbp1 transcription factor, which participates to a transcription
program in order to first re-establish ER function and cell survival.
The chaperone GRP78 also regulates the pro-survival pathway
during ER stress through its up-regulation. However, we were not
able to observe such regulation in U2OS and SW480 cells silenced
for Scd1 48 h post-transfection (Figure 3C). We did not observe
any change in mRNA and protein level for GRP78 expression at
different post-transfection time (24, 48 and 72 h, data not shown).
PERK also belongs to UPR and its activation induces phosphor-
ylation of eIF2a triggering repression of general translation. We
observed at 48 h post-transfection that cells depleted in Scd1
expressed higher amount of phospho-eIF2a compared to control
cells suggesting activation of the PERK arm (Figure 3D). In order
to assign phosphorylation of eiF2ato Scd1 extinction and not to an
artefact due to PKR activation by siRNA transfection, we analysed
phospho-eIF2a level in U2OS treated with 5 and 10 mM of Scd1
inhibitor (CVT-11127 and MF-438) for 10 and 24 h. We observed
increase of p-eIF2a expression as soon as 10 h for both inhibitors
demonstrating that phosphorylation of eIF2a was induced by
extinction of Scd1 activity (Figure 3E).
CHOP participates to Scd1 depletion-induced cell death
In ER stress-mediated apoptosis, CHOP expression increases
and appears as an essential effector of this cell death program.
We first addressed evaluation of CHOP expression in cancer
cells treated with siRNA scr or against Scd1. We observed an
increase of CHOP mRNA and protein expression in cells that
lost Scd1 expression compared to control cells (Figures 4A and
4B). To ascertain the role of CHOP in cell death induction, we
transiently transfected empty vector (ctr) or dominant-negative
form of CHOP (DN-CHOP) in U2OS cells. DN-CHOP
construct harbours mutations in the leucine zipper domain
(L134A/L141A) that prevents its transcriptional activity [37].
We showed by PI staining that DN-CHOP overexpression
reduced cytotoxicity induced by Scd1 inhibition compared to
the control-transfected cells (ctr) (Figure 4C). Moreover, we
estimated the effect of enforced expression of DN-CHOP on
active caspase 3 induction in Scd1-silenced U2OS. We showed
a decrease of caspase 3 activation in Scd1 knockdown-U2OS
c e l l se x p r e s s i n gD N - C H O Pa n de v i d e n c e dap r o t e c t i v ee f f e c to f
DN-CHOP against apoptosis induced by Scd1 depletion
(Figure 4D).
CHOP extinction partially alleviates Scd1 depletion-
induced apoptosis
The protection observed by CHOP inhibition against Scd1
depletion-mediated U2OS cell death has also been evaluated in
HCT116 colon tumor cell line. In this aim, we used transitory
CHOP knockdown-HCT116 and BA1 cells that are HCT116 cells
stably transfected with antisense human CHOP cDNA construct
[38]. Depletion of Scd1 with siRNA in HCT116 induced more
than 30% of cell death as attested by PI staining (Figure 5A). We
also showed at 72 h that extinction of Scd1 activity by siRNA and
inhibitors (data not shown) induced apoptosis in HCT116
evidenced by active caspase 3 or PARP-cleavage detection
(Figures 5B and 5C). In those cells, we also found that abolition
of Scd1 expression led to up-regulation of CHOP mRNA
expression as already observed for U2OS and SW480 cells
(Figure 5D). Furthermore, we confirmed as in U2OS that
reduction of CHOP expression partially alleviated cytotoxicity
induced by Scd1 silencing. Indeed, we observed a diminution of PI
staining in BA1 cells compared to their parental HCT116 (p-
HCT116) counterparts when Scd1 expression was abolished
(Figure 5E). Moreover, the protection against Scd1 silencing-
mediated cell death induced by CHOP extinction seemed to be
specific and not a protection against all pro-apoptotic factors.
Indeed, extinction of CHOP did not modify apoptosis induction
by etoposide in DN-CHOP U2OS or BA1 compared to their
respective control cells (data not shown). We have also undertaken
to evaluate effect of CHOP extinction by siRNA treatment on
apoptosis induced by Scd1 abolition. For this purpose, we
performed co-treatment of HCT116 cells with siRNA control
(scr) or directed against Scd1 (Scd1.A and Scd1.B), and with
siRNA CHOP or control (2).We validated CHOP siRNA in
HCT116 cells and showed that CHOP siRNA did not modify
Scd1 mRNA extinction level induced by Scd1 siRNAs (data not
shown). In order to estimate CHOP function in Scd1-induced
apoptosis, we then performed siRNA co-transfection. We observed
72 h after transfection that CHOP silencing protected HCT116
against apoptosis-cell death induced by Scd1 extinction (Figures 5F
and 5G).
analysed by flow cytometry after staining with propidium iodide (PI). Data represent the mean 6 SEM of three independent experiments. D) U2OS
cells were treated for 48 h with Scd1 inhibitors at indicated concentrations and were harvested for propidium iodide staining. Data represent the
mean 6 SEM from three experiments. E) U2OS cells were collected 72 h post-transfection and prepared for caspase 3 activity measurement by flow
cytometry as detailed in the materials and methods. Data are shown as fold increase over the control (siRNA scr) and represent the mean 6 SEM of
two independent experiments. F) Whole-cell lysates were prepared 72 h post-transfection with siRNA and PARP cleavage (c-PARP) level was
determined by Western-blot. G) U2OS cells were treated for 72 h with siRNA control (scr) and targeting Scd1 in absence (vehicle) or presence of
100 mM oleic acid bound to BSA. Cell number was quantified by CyQuantH proliferation assay as previously described. Data are shown as fold change
over the vehicle siRNA scr-treated cells and represent the mean of relative fluorescence units 6 SEM of triplicate. *, ** p,0.05 vs. siRNA scr-treated
vehicle and oleic acid cells, respectively, by Anova analysis followed by Tuckey test.
doi:10.1371/journal.pone.0014363.g002
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PLoS ONE | www.plosone.org 5 December 2010 | Volume 5 | Issue 12 | e14363Figure 3. Inhibition of Scd1 partially induced UPR markers. U2OS and SW480 cells were treated with siRNA control (scr) and siRNA against
Scd1 for 72h. A) Samples were prepared for mRNA analyses of Xbp1 processing by semi-quantitative RT-PCR. The PCR products were run on a 3%
agarose gel and the spliced Xbp1 (sXbp1), unspliced Xbp1 (uXbp1) and hybrid Xbp1 (hXbp1) mRNA species were observed in siRNA-treated cells (ctr)
and thapsigargine-treated cells (Tg) as positive control of UPR activation. B) Total protein lysates were prepared from untreated and thapsigargin-
treated cells (Tg, 0.2 mM, 16 h) and analysed for eiF2a phosphorylation and GRP78 up-regulation by western-blotting. C and D) Scd1-depleted U2OS
and SW480 cells were prepared as in 3B) and analysed by western-blotting for Scd1, GRP78 and phospho-eiF2a expression. E) U2OS cells were
treated with 5 and 10 mM of Scd1 inhibitors (MF-438 and CVT-11127) and were collected after 10 h and 24 h of treatment for phospho-eiF2a
expression analysis by western-blotting. Blots are representative of at least two independent experiments.
doi:10.1371/journal.pone.0014363.g003
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PLoS ONE | www.plosone.org 6 December 2010 | Volume 5 | Issue 12 | e14363Figure 4. Inhibition of CHOP activity reduced siRNA Scd1-mediated U2OS cell death. A) U2OS and SW480 cells were treated with siRNA
control (scr) and siRNA against Scd1 for 72h. Total RNA was isolated and CHOP mRNA expression normalized to b-actin mRNA expression was
quantified by real time RT-PCR. Results were represented as mean fold induction 6 SEM relative to siRNA scr-treated cells from at least three
independent experiments. *, p,0.05 vs. siRNA scr-treated cells by Anova analysis followed by Tuckey test. B) Nuclear extracts from U2OS were
prepared 72 h after siRNA addition. CHOP expression was analysed by western-blotting and lamin A/C was loading control of nuclear extract samples.
C) U2OS cells were transiently transfected with empty (ctr) or dominant-negative CHOP (DN-CHOP) expression vector and selected for three days in
G418. Resistant cells transfected by ctr or DN-CHOP construct were treated by siRNA control scr or against Scd1 (Scd1.A and Scd1.B) for 72 h and
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cells
Cancer cells were sensitive to Scd1 depletion-mediated cell
death.We were then interested in analysing the potential effect of
an absence of de novo MUFA synthesis in non cancer cells. In this
aim, we evaluated impact of Scd1 inhibition using siRNA on
normal human dermal fibroblasts (NHDF). These cells have a
basal desaturation rate about 15% lower than U2OS and SW480
cells as shown previously in Figure 1C. Their treatment with
siRNA Scd1.A or Scd1.B led to a reduction of Scd activity to reach
a remaining activity of 8.3% and 6.3%, respectively (Figure 6B).
The residual Scd activity was similar to the one obtained for
cancer cells treated with the siRNA Scd1. As shown above,
ablation of Scd activity in cancer cells led to cytotoxicity whereas
depletion of Scd1 expression did not induce cell death in NHDF
but reduced very slightly their cell number (Figures 6C and 6D).
Then, in non cancer cells, Scd1 abrogation might block
proliferation without affecting cell viability.
Discussion
In the present study, we demonstrated that Scd1 expression
silencing led to induction of UPR markers (Xbp1 splicing, p-eIF2a
and CHOP) and CHOP-dependent cell death in cancer cells. We
also showed that abrogation of de novo MUFA synthesis pathway
by extinction of its rate-limiting enzyme Scd1 altered viability of
cancer cells without changing the survival of non cancer cells. This
data suggests different needs in de novo MUFA synthesis for
normal and tumoral cells. Nevertheless, exogenous addition of
oleic acid, the major MUFA product of Scd1 activity, did not
prevent cell death of cancer cells in which endogenous MUFA
biosynthesis was suppressed.
In this report, we agree with previous reports describing that
Scd1 extinction led to cell death by apoptosis in different types of
cancer cells [22,25,27,39]. Indeed, we observed induction of
caspase 3 activity and PARP-cleavage (Figures 2D et 2E) in Scd1-
depleted cells.
We also evidenced in this work that normal and cancer cells did
not respond in the same manner to the prevention of MUFA
synthesis by Scd1 extinction. Indeed, while cancer cells were killed
by Scd1 depletion, non cancer cells were still alive. However, we
observed a slight decrease in cell number in Scd1-treated NHDF
that a block or a slower rate of proliferation could explain. We can
then hypothesise that viability of non cancer cells remained
unaffected due to the fact that they do not require such a rapid and
high MUFA synthesis. Indeed, they proliferate at lower rate
(Figure 6C) and preferentially sustained new membrane synthesis
from exogenous fatty acids up-take whereas cancer cells proliferate
at higher rate and need de novo fatty acid synthesis [10].
We and others showed that abolition of Scd1 activity decreased
de novo MUFA production (Figure 1C) and in consequence
increased SFA content (e.g. palmitic and stearic acids)
[22,26,27,40]. Induction of lipotoxicity by SFA in cancer and
non cancer cells has been previously described, and that the level
of Scd1 expression controlled SFA effect since overexpression of
Scd1 reduced SFA-mediated cell death when a down-regulation
increased it [27,29,39,41,42,43]. Among MUFA, oleic acid is the
most represented and has been characterised by cytoprotective
and proliferative actions. Its addition promotes tumoral cell
proliferation that could be obtained through down-regulation of
the tumor suppressor Pten as described for hepatocarcinoma cells
but also prevents palmitate-stimulated apoptosis [29,41,44]. As
already reported for SV40-tranformed lung fibroblasts lacking
Scd1 expression, we were not able to observe any rescue of siRNA
Scd1-induced U2OS cell death (Figure 2F) [39]. This observation
is in discrepancy with recent results indicating that oleic acid could
reverse the impairing effects of Scd1 depletion on proliferation and
survival in Hela and H460 tumor cells [27,45]. A possible
mechanism of oleic acid protection is the increase of triglyceride
production that could incorporate SFA excess into triglycerides
and protects cells from apoptosis [45,46]. The observed discrep-
ancy could be due to a different ability of Scd1-depleted U2OS
cells placed under oleic acid supplementation to channel SFA into
triglyceride pool.
Scd1 controls the de novo synthesis of MUFA, and, more
globally appears as a key regulator of lipid metabolism. In order to
maintain their high proliferating rate, cancer cells require an
elevated production of cellular membrane components membrane
such as cholesterol and phospholipids [47,48]. Interfering with the
phospholipid Kennedy’s pathway is described to block phospho-
lipid synthesis and to induce apoptosis [30,49,50]. Thus, extinction
of Scd1 activity decreases de novo phospholipid and neutral lipid
synthesis, and cell death obtained by Scd1 depletion in different
cancer cells could be related to this change [39].
On the other hand, the phospholipid remodelling which
represented the decrease of unsaturated fatty acid incorporation
consecutive to Scd1 depletion played a predominant role in cell
survival by triggering cell death [27].
Thus, both phospholipid synthesis and remodelling pathways
seemed to be involved in Scd1 inhibition-mediated cell death.
Additionally, changes in phospholipid metabolism can induce ER
stress response that could explain its activation in Scd1-depleted
cells [30].
Indeed, we clearly showed, in the present study, a peculiar ER
stress activation since GRP78 expression was not modified.
GRP78, a stress-inducible chaperone localized in the ER, is a
key component of the UPR required to alleviate ER stress,
maintain ER function and protect cells against apoptosis [51].
Lack of anti-apoptotic GRP78 induction could contribute to cell
death in maintaining the three transducers of ER stress (PERK,
IRE1a and ATF6) under an activated status and down-regulation
of GRP78 is known to sensitize tumor cells to apoptosis induced by
current anti-cancer therapies [52,53,54]. The observation con-
cerning GRP78 expression in Scd1-depleted cells was not related
to the inability of U2OS and SW480 cells to increase GRP78
expression in ER stress response since thapsigargin-treated cells
overexpressed GRP78 protein. Few reports already mentioned
such a lack of GRP78 induction during ER stress. Among them,
inhibition of phosphatidylcholine synthesis, treatment with
palmitic acid or trans 10, cis 12-conjugated linoleic acid triggered
ER stress and cell death without affecting GRP78 content
[30,55,56].
harvested for propidium iodide staining analysis by flow cytometry. Values were shown as fold increase over the controls (siRNA scr) and represent
the mean 6 SEM of two independent experiments. *, **, p,0.05 vs. siRNA scr-treated ctr and DN-CHOP cells, respectively, by Anova analysis followed
by Tuckey test. #,p ,0.05 by Anova analysis followed by Tuckey test. D) U2OS cells were prepared as C) and harvested for active caspase 3 analysis
by flow cytometry. Values were shown as fold increase over the controls (siRNA scr) and represent the mean 6 SEM of three independent
experiments. *, **, p,0.05 vs. siRNA scr-treated ctr and DN-CHOP cells, respectively, by Anova analysis followed by Tuckey test. #,p ,0.05 by Anova
analysis followed by Tuckey test.
doi:10.1371/journal.pone.0014363.g004
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PLoS ONE | www.plosone.org 8 December 2010 | Volume 5 | Issue 12 | e14363Figure 5. Extinction of CHOP expression reduced Scd1 knockdown-mediated HCT116 apoptosis. A) HCT116 cells treated 72 h with
siRNA control (scr) or targeting Scd1 (Scd1.A and Scd1.B) were collected and total cell death was analysed by flow cytometry after staining with
propidium iodide. Results were the mean 6 SEM of three experiments performed in triplicate. B) HCT116 cells treated by siRNA were collected 72 h
post-transfection and prepared for caspase 3 activity measurement by flow cytometry as detailed in the materials and methods. Data represent the
mean 6 SEM of three independent experiments. C) HCT116 were treated as in A) and harvested for analysis of Scd1 and PARP-cleavage expression by
Western-blotting. D) HCT116 were treated as in A) and harvested for total RNA purification. CHOP and Scd1 mRNA expression was analyzed by real
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PLoS ONE | www.plosone.org 9 December 2010 | Volume 5 | Issue 12 | e14363We pointed out in the present study that the extinction of de
novo MUFA synthesis via Scd1 knockdown led to the most
characteristic UPR induction with activation of PERK and IRE1a
arms. Indeed, Scd1 depletion-induced ER stress triggered Xbp1
mRNA splicing (Figure 3A) demonstrating activation of IRE1a
arm as previously described [57]. Xbp1 processing, even partial,
highlighted IRE1a activation through dissociation from GRP78 in
response to Scd1 inhibition. This data was confirmed by the
increased amount of phospho-eIF2athat we observed in Scd1-
depleted cells indicating activation of PERK via its dissociation
from GRP78 (Figure 3D). Phosphorylation of eIF2a leads to
inhibition of global translation, concomitant with selective
translation of a subset of transcripts including the ATF4
transcription factor, to first cope with ER stress and restore ER
function [33].
However, activation of PERK arm was also described as part of
a pathway involved in cell death [58]. Thus, Ariyama et al. showed
that Scd1 extinction triggered PERK activation and confirmed
that PERK arm could be a pro-apoptotic signal in preventing
Scd1 extinction-mediated cell death by down-regulating PERK
expression [27]. Our observation on phosphorylation of eIF2a
highlighted data about PERK activation in Scd1-ablated cells but
others stress-inducible eIF2a kinases (e.g. GCN2, PKR) could also
induce this post-translational modification and the associated cell
death [59].
The phosphorylation of eIF2a triggers ATF4 mRNA transla-
tion, which is known to up-regulate the expression of the pro-
apoptotic transcription factor CHOP in cellular stress context
[33]. CHOP could trigger apoptosis at least through transcription
induction of pro-apoptotic genes (e.g. BIM) and transcription
repression of anti-apoptotic ones (e.g. Bcl-2) [34,60]. Here, we
confirmed that Scd1 knockdown enhanced CHOP expression and
activated apoptosis evidenced by PARP-cleavage and active
caspase 3 production. Although CHOP inactivation led to a
decrease of apoptosis induction in Scd1-depleted cells, we were not
able to fully restore the viability suggesting that other pathways are
probably involved in cell death induced by Scd1 inactivation.
During severe ER stress, apoptosis at least appears through CHOP
induction. However, caspase 12 (in rodents) and JNK pathway are
also involved in ER stress-mediated apoptosis and might
participate to Scd1 extinction-induced apoptosis [61].
In conclusion, our results provided evidences that Scd1
extinction induced UPR and cell death in cancer cells through
CHOP activation. Thus, this study highlights that components of
de novo MUFA synthesis and UPR pathway represent promising
targets for cancer therapy.
Materials and Methods
Materials
U2OS human osteosarcoma cancer cells, SW480 human
colorectal adenocarcinoma cancer cells were obtained from
American Type Culture Collection (Rockville, MD). BA1 cells
stably expressing human CHOP antisense cDNA construct and
their parental HCT116 cells counterparts were graciously given by
Dr. Jesse Martinez. Normal human dermal fibroblasts (NHDF)
were obtained from Invitrogen (Cergy-Pontoise, France). Cell
culture supplies were from Dutscher (France). Anti-Scd1, anti-
CHOP/GADD153, anti-GRP78 were purchased from Santa-
Cruz biotechnologies, anti-peIF2a, anti-cleaved PARP, anti-lamin
A/C from Cell Signaling Technology and anti-b-actin from
Sigma. Oleic acid was obtained from NuCheck Prep (Elysian,
MN) and [
14C] stearic acid from Perkin-Elmer (Courtaboeuf,
France). Scd1 inhibitors CVT-11127 and MF-438 were generous
gift from Gilead Sciences, Inc. and Merck Frosst, respectively
[62,63].
Cell culture and transfections
U2OS, SW480, HCT116 cells were maintained in DMEM
supplemented with 10% heat inactivated foetal bovine serum
(FBS), penicillin (100 U/ml), streptomycin (100 mg/ml), L-gluta-
mine (2 mM). NHDF were cultivated in MEM106 (Invitrogen)
supplemented with LSGS (Invitrogen), 10% heat inactivated FBS,
penicillin (100 U/ml), streptomycin (100 mg/ml), L-glutamine
(2 mM). For experiments of fatty acid supplementation, oleic acid
bound to BSA (ratio 4:1) was used at 100 mM.
Small interfering RNAs (siRNA) were synthesized by Dharma-
con Research Inc. (Lafayette, CO) and were transfected into cells
with Oligofectamine (Invitrogen) according to the manufacturer’s
recommendations. Transfected cells were collected at indicated
post-transfection time. siRNA control (scr) targets unrelated
human mRNA CUUACGCUGAGUACUUCG; siRNAs against
Scd1 target GAUAUGCUGUGGUGCUUAA (Scd1A) and
GAGAUAAGUUGGAGACGAU (Scd1.B); siRNA CHOP tar-
gets CAAUUGUUCAUGCUUGGUG sequence [25].
Scd1 inhibitors CVT-11127 (Gilead Sciences, Inc.) and MF-438
(Merck Frosst) were dissolved in DMSO and used at indicated
concentrations [62,63].
U2OS were transiently transfected with empty or dominant-
negative CHOP (DN-CHOP) expression vector with lipofecta-
mine 2000 (Invitrogen) and selected next day in G418 (400 mg/ml)
for three days. Then, cells were trypsinised and seeded at 130
000 cells/well in 6-well plate. Next day, siRNA transfection was
performed as described above.
Cell proliferation, viability and death analyses
Cell proliferation analysis was carried out using CyQuantH NF
cell proliferation assay (Invitrogen). Adherent cells were washed
and frozen at –80uC. Cells were thawed and treated with
CyQuant GR dye, which binds stoichiometrically to nucleic acids
and, thus, measures cell number. Fluorescence quantification was
measured using a microtiter plate fluorimeter (VICTOR
3V
TM,
PerkinElmer Life Sciences Inc., Wellesley, MA) with excitation at
485 nm and detection at 535 nm.
Cell viability was evaluated by trypan blue exclusion assay using
phase contrast microscopy at indicated time after siRNA
time RT-PCR after normalization to b-actin. All experiments represent at least two repetitions in triplicate. E) HCT116 cells were stably transfected with
antisense human CHOP cDNA construct and its empty control vector. BA1 and p-HCT116 are HCT116 clones with antisense CHOP construct and
control vector, respectively. Cells were silenced by siRNA Scd1.A and Scd1.B for 72 h, and harvested for total cell death analysis by flow cytometry
after staining with propidium iodide. Results were the mean of fold change for PI positive cells relative to the corresponding siRNA scr HCT116 cells 6
SEM of one representative experiment from three experiments performed in triplicate. *, **, p,0.05 vs. siRNA scr-treated p-HCT116 and BA1 cells,
respectively, by Anova analysis followed by Tuckey test. #,p ,0.05 by Anova analysis followed by Tuckey test. F) and G) HCT116 cells were
transfected with siRNA scr, Scd1.A or Scd1.B at 75 nM, and either with 25 nM siRNA scr (-) or siRNA CHOP. Cells were collected at 72 h post-
transfection for PI staining and active caspase 3 analyses by flow cytometry. Results were the mean 6 SEM of one representative experiment from
two independent experiments performed in triplicate. *, **, p,0.05 vs. corresponding siRNA scr-treated HCT116 cells by Anova analysis followed by
Tuckey test. #,p ,0.05 by Anova analysis followed by Tuckey test.
doi:10.1371/journal.pone.0014363.g005
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PLoS ONE | www.plosone.org 10 December 2010 | Volume 5 | Issue 12 | e14363Figure 6. Scd1 depletion did not affect viability of non cancer cells. Normal human dermal fibroblasts (NHDF) were transfected with siRNA
control (scr) and siRNA targeting Scd1 (Scd1.A and Scd1.B). NHDF cells were harvested after 72 h siRNA treatment and harvested for further analyses.
A) Total proteins were prepared for Scd1 expression analysis by western-blotting. B) NHDF treated 72 h with siRNA were incubated for further 6 h
with [
14C] stearic acid and total lipid extraction was carried out. Conversion of [
14C] stearic acid into oleic acid was performed by HPLC. Scd activity
was expressed as the % ratio of [
14C] oleic acid to [
14C] oleic and stearic acids. Values represent the mean 6 SEM for at least two separate
experiments. C) Proliferation status of siRNA-treated NHDF was determined at indicated time by the CyQuantH proliferation assay. Each value is the
mean of relative fluorescence units 6 SEM of three independent experiments. D) NHDF were collected 72 h post-transfection and total cell death
analysis was performed by flow cytometry after staining with propidium iodide. Results were the mean 6 SEM of PI positive cells (%) of one
representative from two experiments performed in triplicate. *, p,0.05 vs. siRNA scr-treated cells by Anova analysis followed by Tuckey test.
doi:10.1371/journal.pone.0014363.g006
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PLoS ONE | www.plosone.org 11 December 2010 | Volume 5 | Issue 12 | e14363treatment. Cells that exclude trypan blue dye are considered to be
viable.
Total cell death was determined by propidium iodide staining
(PI) using flow cytometry (FACSCalibur, Becton Dickinson). Cells
were collected 72 h after siRNA treatment. PI (1 mg/ml) was
added to cells and positive PI staining cells were considered as
dead cells.
Caspase 3 activity was determined using CaspGLOW Fluores-
cein Caspase-3 Staining Kit by flow cytometry. The assay utilizes
the caspase-3 inhibitor, DEVD-FMK, conjugated to FITC (FITC-
DEVD-FMK) that irreversibly binds to activated caspase-3 in
apoptotic cells.
RNA purification and RT-PCR
Total RNA was purified using RNEasy kit (Qiagen, Germany).
Reverse transcription was performed with 1 mg RNA using iScript
cDNA Synthesis Kit (Bio-Rad).
For analysis of Xbp1 mRNA splicing, semi-quantitative PCR
analysis was performed with Gotaq green master mix (Promega)
and the following primers were used:
59-AAACAGAGTAGCAGCTCAGACTGC-39 and 59-TCC-
TTCTGGGTAGACCTCTGGGAG-39; and b-actin: 59-ATGA-
TATCGCCGCGCTCGTCGTC-39 and antisense 59-AGGT-
CCCGG CCAGCCAGGTCCAG-39.
RNA expression level was quantified by real-time PCR using iQ
SYBR Green supermix (Bio-Rad) using a Bio-Rad iCycler iQ with
the following primers:
CHOP: sense 59-ACA CAG ATG AAA ATG GGG GTA
CCT-39 and antisense 59-AGA AGC AGG ATC AAG AGT
GGT-39; Scd1: sense 59-TTC AGA AAC ACA TGC TGA TCC
TCA TAA TTC CC-39 and antisense 59-ATT AAG CAC CAC
AGC ATA TCG CAA GAA AGT CTG-39; b-actin: sense 59-
CTG GTG CCT GGG GCG-39 antisense 59-AGC CTC GCC
TTT GCC GA–39.
Western Blotting
For whole-cell extracts, cells were washed with ice-cold PBS and
lysed in ice-cold triton buffer (Tris-HCL 20 mM pH 7.4, Nacl
150 mM, EDTA 0.5 mM, EGTA 0.5 mM, Triton X-100 1%),
containing protease and phosphatase inhibitor cocktails (Sigma
cocktails I and II) for 15 min on ice. We cleared protein lysate at
10 000 g, 10 min at 4uC. Thirty micrograms of total proteins were
loaded for SDS-PAGE electrophoresis and transferred onto a
nitrocellulose membrane.
For nuclear extracts, cells were washed with ice-cold PBS and
harvested in lysis buffer (10 mM HEPES, pH 7.9, 50 mM NaCl,
0.1 mM EDTA, 500 mM sucrose, 0.5% Triton X-100 with
protease inhibitors as described above. After swelling for 10 min
on ice, cytosolic fraction was obtained by centrifugation at 20006
g for 10 min at 4uC. The pellet was resuspended in nuclei lysis
buffer (10 mM HEPES, pH 7.9, 500 mM NaCl, 0.1 mM EDTA,
0.1 mM EGTA, 0.1% NP-40 with protease inhibitors) and
incubated on ice for 30 min with vortexing every 5 min. The
suspension was centrifuged at 24,0006g for 15 min at 4uC and the
resulting supernatant was the nuclear extract.
Immunoblotting was performed with antibodies raised against
phospho-eIF2a (1/1000), anti-Scd1 (1/500), anti-cleaved PARP
(1/1000), anti-GRP78 (1/200), anti-CHOP/GADD153 (1/200),
anti-lamin A/C (1/1000) and anti-b-actin (1/4000). Horseradish
peroxidase-conjugated secondary antibodies were used at 1/5000.
Determination of Scd activity
We evaluated Scd activity by measuring the conversion of [
14C]
stearic acid into [
14C] oleic acid after siRNA (72 h) or Scd1
inhibitor (24 h) treatment. Cells were incubated with 3 mM
(0,25 mCi/dish of [
14C] stearic acid) for 6 h at 37uC in 5% CO2
incubator. Cells were collected and total lipids were extracted
according to Bligh and Dyer method. Lipids were saponified and
esterified. Radiolabelled fatty acid methyl esters were separated by
RP-HPLC and detected on line by a radioisotope detector
(Packard Flow Scintillation Analyser, PerkinElmer Life Sciences
Inc., Wellesley, MA). The [
14C] oleic acid/([
14C] oleic and stearic
acids) ratio was determined as Scd activity.
Statistical analysis
Results are presented as means 6 standard error mean (SEM).
Statistical significance of results was determined by OneWay
Anova analysis followed by Tuckey HSD test. Values of p,0.05
were considered significant.
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